Metformin - boosts the number of oxygen molecules released into a cell.
A common treatment for diabetes could enable adults to live well into their 120s, scientists say.
They will carry out the first trials on metformin next year in the hope it may stave off illnesses such as Alzheimer’s and Parkinson’s disease.
Researchers have already conducted tests on animals which show it significantly extends their lives.
Now the Food and Drug Administration, the American regulator, has given the go-ahead for the same trials in humans.
If successful, it would mean that, for example, a person in their 70s could have the same biological age as a healthy 50-year-old.
Professor Gordon Lithgow of the Buck Institute for Research on Ageing in California, who will lead the study, said: ‘If you target an ageing process and you slow down ageing then you slow down all the diseases and pathology of ageing as well.
‘That’s revolutionary. That’s never happened before.
Read more: http://www.dailymail.co.uk/health/article-3338807/Diabetes-pill-help-live-120-Common-treatment-set-trialled-year-hope-stave-illnesses-Alzheimer-s-Parkinson-s.html#ixzz3syb92QPo